Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolytic therapy in review

S H Thomas1, S M Shepherd, E J Allison

  • 1Department of Emergency Medicine, East Carolina University School of Medicine/University Medical Center of Eastern Carolina, Greenville, North Carolina 27858-4354.

The Journal of Emergency Medicine
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Meloidogyne aegracyperi</i> n. sp. (Nematoda: Meloidogynidae), a root-knot nematode parasitizing yellow and purple nutsedge in New Mexico.

Journal of nematology·2021
Same author

Characterizing Agreement in the Level of Interarm Blood Pressure Readings of Adults in the Emergency Department (CALIBRATE Study).

Qatar medical journal·2020
Same author

First Report of Columbia Root-Knot Nematode (Meloidogyne chitwoodi) in Potato in New Mexico.

Plant disease·2019
Same author

First Report of Meloidogyne partityla on Pecan in New Mexico.

Plant disease·2019
Same author

First Record of Meloidogyne partityla on Pecan in Georgia.

Plant disease·2019
Same author

Case of Alveolar Exostosis.

The American journal of dental science·2019
Same journal

Mechanical Versus Manual Cardiopulmonary Resuscitation Causing Traumatic Cardiothoracic and Abdominal Injuries: A Meta-Analysis and Systematic Review of Randomized Trials.

The Journal of emergency medicine·2026
Same journal

Drip-and-Ship versus Mothership Model in Acute Ischemic Stroke: A Meta-Analysis Stratified by Stroke System Integration.

The Journal of emergency medicine·2026
Same journal

Response to: "Letter to the Editor Regarding Cervical Spine Clearance in Adult and Pediatric Trauma: A Systematic Review".

The Journal of emergency medicine·2026
Same journal

Ultrasound Characterization of the Distal Thigh Great Saphenous Vein Dimensions in Children and Adults: Implications for Peripheral Rescue Access.

The Journal of emergency medicine·2026
Same journal

A Shadow in the Right Ventricle.

The Journal of emergency medicine·2026
Same journal

Structural Determinants of Telehealth Use Among Patients Presenting to an Urban Safety-Net Emergency Department.

The Journal of emergency medicine·2026
See all related articles

Thrombolytic agents are increasingly used for various conditions, but optimal use and agent selection remain debated. This review covers current thrombolytic therapy for heart attacks, pulmonary embolism, and strokes.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Neurology

Background:

  • Thrombolytic therapy is a rapidly advancing field with ongoing debate regarding its optimal application.
  • Recent research focuses on comparing different thrombolytic agents and dosing strategies to maximize benefits and minimize risks.

Purpose of the Study:

  • To review the current status of thrombolytic therapy for major cardiovascular and cerebrovascular diseases.
  • To discuss the benefits and risks associated with thrombolytic agents in specific clinical scenarios.

Main Methods:

  • Literature review of recent studies on thrombolytic agents.
  • Analysis of therapeutic outcomes and risk profiles for different indications.
  • Synthesis of current evidence for coronary artery disease, pulmonary embolism, peripheral vascular thrombosis, and cerebrovascular infarction.

Related Experiment Videos

Main Results:

  • Thrombolytic therapy is established for acute coronary syndromes and pulmonary embolism.
  • Evidence for peripheral vascular thrombosis and cerebrovascular infarction is more variable and debated.
  • Different agents and regimens show varying efficacy and safety profiles.

Conclusions:

  • Thrombolytic therapy offers significant benefits in specific thrombotic conditions.
  • Careful selection of agents and dosing is crucial for optimal patient outcomes.
  • Further research is needed to refine treatment protocols for all indications.